XML 33 R18.htm IDEA: XBRL DOCUMENT
v3.23.3

Goodwill and Intangible Assets | 12 Months Ended
--- | ---
Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract] |
Goodwill and Intangible Assets | 8. Goodwill and Intangible Assets On April 1, 2023, in accordance with the Company’s policy, the Company performed the annual quantitative goodwill impairment test. As of the annual impairment test date, the estimated fair value of the Life Sciences Services and Life Sciences Products reporting units exceeded their respective carrying values by approximately 24% and 17%, respectively. The Company qualitatively evaluated goodwill for impairment during the remainder of fiscal 2023 and determined that there were no events or circumstances during the period to indicate an additional quantitative goodwill impairment assessment was required. In the event of financial performance of the reporting units does not meet management’s expectations in the future, there is a change to the Company’s reportable segments, the Company experiences a prolonged macroeconomic or market downturn, declines in the Company’s stock price, or there are other negative revisions to key assumptions used in the DCF Method, the Company may be required to perform additional impairment analyses and could be required to recognize an impairment charge. The following table sets forth the changes in the carrying amount of goodwill by reportable segment since September 30, 2021 (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | ​ | ​ |  | ​ | ​
​ | ​ | Life Sciences | ​ | Life Sciences | ​ | ​ | ​
​ | ​ | Products | ​ | Services | ​ | Total
Balance - September 30, 2021 | ​ | $ | 110,138 | ​ | $ | 359,218 | ​ | $ | 469,356
Acquisitions | ​ | ​ | 57,854 | ​ | ​ | — | ​ | ​ | 57,854
Currency translation adjustments | ​ | ​ | (13,380) | ​ | ​ | (207) | ​ | ​ | (13,587)
Balance - September 30, 2022 | ​ | $ | 154,612 | ​ | $ | 359,011 | ​ | $ | 513,623
Acquisitions | ​ |  | 242,789 | ​ |  | — | ​ |  | 242,789
Currency translation adjustments | ​ | ​ | 27,903 | ​ | ​ | 24 | ​ | ​ | 27,927
Balance - September 30, 2023 | ​ | $ | 425,304 | ​ | $ | 359,035 | ​ | $ | 784,339
​ The components of the Company’s identifiable intangible assets as of September 30, 2023 and 2022 are as follows (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | September 30, 2023 | ​ | September 30, 2022
​ | ​ | ​ | ​ | Accumulated | ​ | Net Book | ​ | ​ | ​ | Accumulated | ​ | Net Book
​ |  | Cost |  | Amortization |  | Value |  | Cost |  | Amortization |  | Value
Patents | ​ | $ | 1,226 | ​ | $ | 1,175 | ​ | $ | 51 | ​ | $ | 1,225 | ​ | $ | 1,106 | ​ | $ | 119
Completed technology | ​ |  | 215,430 | ​ |  | 56,021 | ​ |  | 159,409 | ​ |  | 99,525 | ​ |  | 37,991 | ​ |  | 61,534
Trademarks and trade names | ​ |  | 6,630 | ​ |  | 1,445 | ​ |  | 5,185 | ​ |  | 400 | ​ |  | 41 | ​ |  | 359
Non-competition agreements | ​ | ​ | 681 | ​ | ​ | 568 | ​ | ​ | 113 | ​ | ​ | 681 | ​ | ​ | 439 | ​ | ​ | 242
Customer relationships | ​ |  | 290,800 | ​ |  | 161,257 | ​ |  | 129,543 | ​ |  | 246,949 | ​ |  | 130,802 | ​ |  | 116,147
Other intangibles | ​ | ​ | 869 | ​ | ​ | 869 | ​ | ​ | — | ​ | ​ | 202 | ​ | ​ | 202 | ​ | ​ | —
Total | ​ | $ | 515,636 | ​ | $ | 221,335 | ​ | $ | 294,301 | ​ | $ | 348,982 | ​ | $ | 170,581 | ​ | $ | 178,401
​ ​ For further details regarding the increase in the goodwill and intangibles balances from September 30, 2022 to September 30, 2023, which were primarily a result of the B Medical and Ziath acquisitions, please refer to Note 4, Business Combinations. Amortization expense for intangible assets was $48.4 million, $32.3 million, and $37.4 million, respectively, for the fiscal years ended September 30, 2023, 2022 and 2021. Estimated future amortization expense for the intangible assets as of September 30, 2023 is as follows (in thousands): ​
​ | ​ | ​ | ​
2024 | ​ | $ | 49,750
2025 | ​ |  | 48,308
2026 | ​ |  | 44,952
2027 | ​ |  | 36,877
2028 | ​ | ​ | 30,533
Thereafter | ​ | ​ | 83,881
Total | ​ | $ | 294,301
​

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for goodwill and intangible assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 350 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//350/tableOfContent + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration